[Federal Register Volume 87, Number 28 (Thursday, February 10, 2022)]
[Notices]
[Page 7833]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02851]


=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPPT-2021-0254; FRL-9347-03-OCSPP]


Asbestos Part 2: Supplemental Evaluation Including Legacy Uses 
and Associated Disposals of Asbestos; Draft Scope of the Risk 
Evaluation To Be Conducted Under the Toxic Substances Control Act 
(TSCA); Extension of Comment Period

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice; extension of comment period.

-----------------------------------------------------------------------

SUMMARY: In the Federal Register of December 29, 2021, EPA announced 
the availability of and solicited public comment on the draft scope of 
a risk evaluation under the Toxic Substances Control Act (TSCA) for 
Asbestos Part 2: Supplemental Evaluation Including Legacy Uses and 
Associated Disposals of Asbestos. This document extends the comment 
period for 15 days from February 14, 2022, to March 1, 2022.

DATES: The comment period for the notice published on December 29, 
2021, at 86 FR 74088 is extended. Comments, identified by docket 
identification (ID) number EPA-HQ-OPPT-2021-0254, must be received on 
or before March 1, 2022.

ADDRESSES: Submit your comments, identified by ID number EPA-HQ-OPPT-
2021-0254, through the Federal eRulemaking Portal at https://www.regulations.gov. Follow the online instructions for submitting 
comments. Do not submit electronically any information you consider to 
be Confidential Business Information (CBI) or other information whose 
disclosure is restricted by statute. Additional instructions on 
commenting or visiting the docket, along with more information about 
dockets generally, is available at https://www.epa.gov/dockets/about-epa-dockets.
    Due to the public health concerns related to COVID-19, the EPA 
Docket Center (EPA/DC) and Reading Room is open to visitors by 
appointment only. The staff continues to provide remote customer 
service via email, phone, and webform. For the latest status 
information on EPA/DC services and docket access, visit https://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: 
    For technical information contact: Peter Gimlin, Existing Chemical 
Risk Management Division (Mail Code 7404T), Office of Pollution 
Prevention and Toxics, Environmental Protection Agency, 1200 
Pennsylvania Ave. NW, Washington, DC 20460-0001; telephone number: 
(202) 566-0515; email address: [email protected].
    For general information contact: The TSCA-Hotline, ABVI-Goodwill, 
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202) 
554-1404; email address: [email protected].

SUPPLEMENTARY INFORMATION: This document extends the public comment 
period established in the Federal Register document of December 29, 
2021 (86 FR 74088) (FRL-9347-01-OCSPP) for 15 days, from February 14, 
2022, to March 1, 2022. In that document, in accordance with 
implementing regulations for the Toxic Substances Control Act (TSCA), 
EPA announced the availability of and solicited public comment on the 
draft scope of the risk evaluation for Asbestos Part 2: Supplemental 
Evaluation Including Legacy Uses and Associated Disposals of Asbestos. 
More information on EPA's draft risk assessment and solicitation of 
comment can be found in the Federal Register of December 29, 2021.
    EPA received requests to extend the comment period and believes it 
is appropriate to do so in order to give stakeholders additional time 
to review the draft scope document and prepare comments.
    To submit comments, or access the docket, please follow the 
detailed instructions provided under ADDRESSES. If you have questions, 
consult the technical person listed under FOR FURTHER INFORMATION 
CONTACT.

Michal Freedhoff,
Assistant Administrator, Office of Chemical Safety and Pollution 
Prevention.
[FR Doc. 2022-02851 Filed 2-9-22; 8:45 am]
BILLING CODE 6560-50-P